She Beast Peptides sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
Price range: $75.00 through $225.00
IGF-1 LR3 is a peptide-based research material studied within controlled laboratory environments examining molecular characteristics, peptide-related analytical activity, and biochemical interaction pathways. Researchers commonly investigate IGF-1 LR3 across scientific models involving molecular communication processes, compound stability, and laboratory-based analytical research applications associated with non-clinical scientific investigation.
IGF-1 LR3 is supplied as a laboratory research material intended strictly for analytical and non-clinical scientific environments. This peptide-based compound is commonly evaluated within controlled laboratory studies involving molecular characterization, peptide-related analytical activity, and compound interaction properties under research conditions.
Researchers may utilize IGF-1 LR3 within laboratory environments designed to evaluate molecular behavior and analytical characteristics while maintaining controlled scientific procedures and laboratory-focused handling standards. The material is supplied to support scientific investigation and research-oriented analytical applications.
Each vial is supplied as laboratory research material prepared under controlled handling standards and may include batch-level analytical documentation supporting consistency and laboratory reference applications.
Molecular Formula: Peptide Material
Molecular Weight: Molecular characteristics vary by compound structure
Storage: Store according to laboratory handling and storage procedures
FOR RESEARCH USE ONLY
| Select Mg | 0.1mg, 1mg |
|---|
Reviews
There are no reviews yet.